Sumatriptan Dosing for Migraine
For adults with normal hepatic and renal function, start with sumatriptan 50 mg orally at migraine onset, which offers the optimal balance of efficacy and tolerability, though 100 mg may be used for patients requiring greater efficacy who tolerate the higher dose well. 1
Standard Dosing Algorithm
Initial Dose Selection
- Start with 50 mg orally for most patients, as this dose provides the best efficacy-to-tolerability ratio 2, 3
- Consider 100 mg for patients with severe attacks or those who have previously required higher doses 1, 2
- Use 25 mg only for patients concerned about tolerability or as a trial dose 1, 3
Efficacy by Dose
- 100 mg: Pain-free at 2 hours in approximately 59% of patients (NNT 5.1) 4
- 50 mg: Headache relief at 2 hours (NNT 3.2), though pain-free response not significantly different from placebo in smaller trials 4
- 25 mg: Headache relief at 2 hours (NNT 3.4), pain-free response (NNT 7.5) 4
Repeat Dosing
- If headache persists or returns after 2 hours, administer a second dose at least 2 hours after the first 1
- Maximum daily dose: 200 mg in 24 hours 1
- Critical frequency limit: Use no more than 2 days per week to prevent medication-overuse headache 5
Hepatic Impairment Dosing
Mild to Moderate Hepatic Impairment
Severe Hepatic Impairment
Renal Impairment Considerations
- No specific dose adjustment required for renal impairment, as sumatriptan is primarily metabolized hepatically 1
- However, use caution in elderly patients with multiple comorbidities including renal dysfunction 1
Route Selection Based on Clinical Presentation
Oral Route (Standard)
Alternative Routes When Oral Fails
- Subcutaneous 6 mg: Highest efficacy (70-80% relief within 1 hour), fastest onset (15 minutes) 5, 6
- Intranasal 5-20 mg: Useful when significant nausea or vomiting present 5
Critical Contraindications to Screen For
Before prescribing sumatriptan, ensure the patient does NOT have:
- Ischemic heart disease or previous myocardial infarction 7, 6
- Uncontrolled hypertension 7, 6
- Hemiplegic or basilar migraine 7
- Recent ergotamine use (within 24 hours) 7
- Recent use of another triptan (within 24 hours) 7
- Severe hepatic impairment 1
Common Adverse Events to Counsel About
- Chest pressure, tightness, or heaviness (3-5% of patients) - usually benign but requires cardiovascular evaluation if persistent 7, 6
- Numbness and tingling in extremities - common, mild, transient 7
- Nausea, vomiting, dry mouth 7
- Malaise, vertigo, neck/throat/jaw discomfort 7
Special Populations
Adolescents (12-17 years)
- Oral sumatriptan NOT recommended - trials failed to demonstrate efficacy over placebo 1
- Intranasal sumatriptan 5-10 mg is the only FDA-approved formulation for this age group 8
Elderly (≥65 years)
- Start at low end of dosing range (25-50 mg) 1
- Perform cardiovascular evaluation before initiating if other risk factors present 1
Pregnancy
- Use only under strict specialist supervision 7
- Animal studies showed decreased pup survival at doses 3-5 times human exposure 1
Breastfeeding
- Avoid breastfeeding for 12 hours after dose to minimize infant exposure 1
Headache Recurrence Management
- Approximately 40% of patients experience recurrence within 24-48 hours regardless of route 9, 6
- Second dose may be given at least 2 hours after first dose 1
- If recurrence is consistent pattern, consider combination therapy with NSAID (naproxen 500 mg) for superior sustained relief 5
When to Switch or Escalate
If Sumatriptan Fails After 2-3 Attacks
- Try a different triptan first - failure of one does not predict failure of others 5
- Consider rizatriptan 10 mg (fastest oral triptan), eletriptan 40 mg, or zolmitriptan 2.5-5 mg 5
If All Triptans Fail
- Escalate to gepants (ubrogepant 50-100 mg or rimegepant) 5
- Consider lasmiditan 50-200 mg (no vasoconstriction, safe in cardiovascular disease) 5
If Requiring Acute Treatment >2 Days/Week
- Initiate preventive therapy immediately to avoid medication-overuse headache 5